The rapid advancements in quantum computing are revolutionizing the drug-development process by reducing the time it takes to bring new treatments into the market from years to weeks. According to POLARISqb CTO and cofounder, Bill Shipman, company officials extract actionable time in decreasing delivery costs and time. Currently, drug discovery and development take at least 12 years, but with quantum computing, this period will be shortened to mere weeks.
What’s so fascinating about quantum computing is its ability to simulate complex molecular modeling and simulation with unprecedented accuracy. Molecular modeling and simulations play a critical role in elucidating the interactions between prospective drugs and biological systems. The biggest issue with traditional computing is the computational complexity of simulating large molecules and their interactions, resulting in healthcare supply-chain problems.
Quantum computing leverages the core principle of quantum mechanics to be faster and more efficient than traditional computers, allowing them to tackle highly complex calculations at speeds unthinkable by conventional technology. This advantage will translate to significant benefits during the drug-development pipeline.
In the initial stages of the drug-discovery phase, quantum algorithms rapidly sift through vast libraries of potential drug compounds, identifying the most promising candidates based on their predicted binding affinity and activity. Thanks to this, there is a dramatic reduction in the number of molecules that need to be synthesized and tested in the lab, thus accelerating the path to clinical trials.
Additionally, quantum computing can facilitate the enhancement of drug formulations and doses. This technology can review a large amount of patient data and the genetic profile for individually tailored treatments. This personalized approach to patient treatment will ease doctors’ jobs and determine how they prescribe medication, thus resulting in effective treatments with far fewer side effects.
However, the benefits of quantum computing don’t end there; the technology can also determine how a drug will interact with the patient once consumed. Scientists believe that when designing effective and efficient drugs, they must deeply understand how drug molecules target and interact with biological molecules. They believe when simulating the complex pharmacokinetics and pharmacodynamics of a drug, they can better understand how it interacts with molecules in the body and how it is absorbed, distributed, metabolized and excreted. Scientists believe that the clinical trial process can be streamlined, thus reducing the time and costs necessary for demonstrating a drug’s safety and efficacy.
Despite these promising advantages, quantum computing is still in its infancy. Therefore, scientists must grapple with challenges such as maintaining the stability of quantum states and scaling quantum systems to ensure that quantum computing can handle real-world applications robustly.
Companies such as D-Wave Quantum Inc. (NYSE: QBTS) that supply entities such as POLARISqb with the quantum-computing systems that they are using to speed up drug delivery are likely to play a pivotal role in revolutionizing drug discovery and development in the years to come.
NOTE TO INVESTORS: The latest news and updates relating to D-Wave Quantum Inc. (NYSE: QBTS) are available in the company’s newsroom at https://ibn.fm/QBTS
About BillionDollarClub
BillionDollarClub (“BDC”) is a specialized communications platform with a focus on the biggest and brightest companies covered by IBN. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BDC is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, BDC brings its clients unparalleled recognition and brand awareness.
BDC is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BillionDollarClub, text “Billion” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BillionDollarClub.com
Please see full terms of use and disclaimers on the BillionDollarClub website applicable to all content provided by BDC, wherever published or re-published: https://www.BillionDollarClub.com/Disclaimer
BillionDollarClub
Los Angeles, CA
www.BillionDollarClub.com
310.299.1717 Office
Editor@BillionDollarClub.com
BillionDollarClub is powered by IBN
Electric vehicles (EVs) are growing in popularity across Europe as part of the fight against…
Electric vehicle (EV) sales in the United States are picking up speed. According to new…
Toyota is making bold moves in the electric vehicle industry. The company plans to triple…
The United States government has placed new sanctions on eight cryptocurrency wallet addresses. These wallets…
As e-commerce grows quickly across Europe, online retailers are facing a major problem: managing huge…
D-Wave’s research shows that quantum-based blockchain operations could use up to 1,000 times less electricity…